Medizinische Universität Graz - Research portal
Spiegl Benjamin Gernot |
** = Publications listed in SCI/SSCI/Pubmed
2024
Full paper/article (Journal)
** Lazzeri, I; Spiegl, BG; Hasenleithner, SO; Speicher, MR; Kircher, M
LBFextract: Unveiling transcription factor dynamics from liquid biopsy data
COMPUT STRUCT BIOTEC. 2024; 23: 3163-3174.
Doi: 10.1016/j.csbj.2024.08.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Full paper/article (Journal)
** Spiegl, B; Kapidzic, F; Röner, S; Kircher, M; Speicher, MR
GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level.
NAR GENOM BIOINFORM. 2023; 5(4): lqad102
Doi: 10.1093/nargab/lqad102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Full paper/article (Journal)
** Sorger, H; Dey, S; Vieyra-Garcia, PA; Pölöske, D; Teufelberger, AR; de, Araujo, ED; Sedighi, A; Graf, R; Spiegl, B; Lazzeri, I; Braun, T; Garces, de, Los, Fayos, Alonso, I; Schlederer, M; Timelthaler, G; Kodajova, P; Pirker, C; Surbek, M; Machtinger, M; Graier, T; Perchthaler, I; Pan, Y; Fink-Puches, R; Cerroni, L; Ober, J; Otte, M; Albrecht, JD; Tin, G; Abdeldayem, A; Manaswiyoungkul, P; Olaoye, OO; Metzelder, ML; Orlova, A; Berger, W; Wobser, M; Nicolay, JP; André, F; Nguyen, VA; Neubauer, HA; Fleck, R; Merkel, O; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
EMBO Mol Med. 2022; 14(12):e15200
Doi: 10.15252/emmm.202115200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML; Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Heitzer, E; Groen, HJM
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
JCO PRECIS ONCOL. 2021; 5: 1540-1553.
Doi: 10.1200/PO.21.00182
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Dey, S; Sorger, H; Vieyra-Garcia, P; Araujo, ED; Graf, R; Spiegl, B; Schlederer, M; Graier, T; Perchthaler, I; Fink-Puches, R; Cerroni, L; Surbek, M; Pirker, C; Berger, W; Orlova, A; Herling, M; Merkel, O; Neubauer, HA; Gunning, PT; Heitzer, E; Kenner, L; Moriggl, R; Wolf, P
STAT5 is a therapeutically targetable vulnerability in leukemic cutaneous T-cell lymphoma
EXP DERMATOL. 2021; 30(3):E100-E101.
[Poster]
Web of Science
** Dey, S; Sorger, H; Vieyra-Garcia, PA; de Araujo, ED; Graf, R; Spiegl, B; Lazzeri, I; Herling, M; Neubauer, HA; Merkel, O; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
Chromosome # 17q (17q11.2-17q21.31) gain is a disease marker and therapeutic vulnerability in Sezary Syndrome
EXP DERMATOL. 2021; 30: 14-14.-4th Inflammatory Skin Disease Summit; NOV 03-06, 2021; New York, NY.
[Poster]
Web of Science
2020
Full paper/article (Journal)
** Weber, S; Spiegl, B; Perakis, SO; Ulz, CM; Abuja, PM; Kashofer, K; Leest, PV; Azpurua, MA; Tamminga, M; Brudzewsky, D; Rothwell, DG; Mohan, S; Sartori, A; Lampignano, R; Konigshofer, Y; Sprenger-Haussels, M; Wikman, H; Bergheim, IR; Kloten, V; Schuuring, E; Speicher, MR; Heitzer, E
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling.
Cancers (Basel). 2020; 12(6): 1588
Doi: 10.3390/cancers12061588
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG